Product Detail
Tafinlar-Dabrafenib mesylate Capsules
Detailed inquiry page for product identification, sourcing review, document preparation, and shipment planning.
Inquiry review onlyNo online sale impliedDocument check required
Product Review Summary
1
CategoryAdditional Sourcing Items
2
Inquiry TypePrescription medicine sourcing review
3
AvailabilityConfirmed after destination and document review
Product Information
Identification details
| Product Name | Tafinlar-Dabrafenib mesylate Capsules |
|---|---|
| Therapeutic / Supply Category | Additional Sourcing Items |
| Trade Name | Tafinlar |
| Generic Name | Dabrafenib mesylate Capsules |
| Strength / Pack Size | 75mg*120Capsules/bottle/pack |
| Manufacturer | Siegfried Barbera, S.L.; Novartis Pharmaceutical |
| MA Holder | Novartis Europharm Limited(Ireland)Manufacturing |
| Approval / Registration | HJ20190066 |
Inquiry Requirements
What MEDIHALL needs to review this product
Product matchConfirm brand/generic name, dosage form, strength, package size, and target quantity.
Destination and purposeShare destination country, consignee type, project purpose, and target timeline.
Document checklistTell us whether invoice, packing list, certificate, registration, customs, or buyer-specific documents are needed.
Handling conditionsConfirm cold-chain, shelf-life, storage, urgency, and shipment handover requirements.
Availability reviewMEDIHALL reviews supply feasibility after product and destination details are clear.
Compliance noteProduct listing does not guarantee availability and does not imply direct online sale.
Related Products
Similar inquiry items
Inquiry
Ask MEDIHALL to review Tafinlar-Dabrafenib mesylate Capsules
Send product details, destination country, quantity, timeline, and document requirements for review.
Email:
Phone: